semaglutide plus cagrilintide Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study Cagrilintide + Semaglutide — Factor

doi: 10.1136/bmj.d7771 34 MeierJJ

Double-strand break (DSB) assay in Xenopus egg extracts DSB reactions were performed as described previously (Barrows et al., 2022)

A separate 2025 narrative review by McGuire and colleagues asked a blunter question in its title: "Regeneration or Risk?" [2] Their conclusion: the preclinical evidence is consistently positive, but the absence of human data makes it impossible to generate evidence-based practice guidelines

A desthiobiotin labelled NAD(+) analogue to uncover Poly(ADP-ribose) polymerase 1 [PMID: 38236015] Laboratory literature summary: A desthiobiotin labelled NAD(+) analogue to uncover Poly(ADP-ribose) polymerase 1 protein targets

Honest Review and What Customers Say is a useful companion read

253 - 274, Book Chapters | 2018 Praharaj S